VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Non-Current Assets History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Assets | ₹264 Cr | ₹267 Cr | ₹278 Cr | ₹301 Cr | ₹322 Cr |
What is the latest Total Non-Current Assets ratio of VENUS REMEDIES ?
Year | Total Non-Current Assets |
---|---|
Mar2025 | ₹264 Cr |
Mar2024 | ₹267 Cr |
Mar2023 | ₹278 Cr |
Mar2022 | ₹301 Cr |
Mar2021 | ₹322 Cr |
How is Total Non-Current Assets of VENUS REMEDIES Trending?
Years | Total Non-Current Assets | % Change | |
---|---|---|---|
Mar2025 | ₹264 Cr | -1.23 | |
Mar2024 | ₹267 Cr | -3.93 | |
Mar2023 | ₹278 Cr | -7.59 | |
Mar2022 | ₹301 Cr | -6.44 | |
Mar2021 | ₹322 Cr | - |
Compare Total Non-Current Assets of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹606.9 Cr | -0.2% | 0% | 34.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹396,862.0 Cr | 1.4% | 2.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,125.0 Cr | 7.1% | 8.8% | 10.3% | Stock Analytics | |
CIPLA | ₹125,454.0 Cr | 3.9% | -1.3% | -3.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,106.0 Cr | -1.3% | -1.3% | 2.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,263.0 Cr | 0.2% | -6% | -4.1% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | -0.2% |
0% |
34.2% |
SENSEX | 0.1% |
0.6% |
0.7% |
You may also like the below Video Courses